Ibrutinib 140 mg - Ibrucent
Share
Ibrucent 140 (Ibrutinib) is a kinase inhibitor used to treat:
1. Mantle cell lymphoma (MCL) who have received at least one prior therapy.
2.
Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)..
4. Waldenström’s macroglobulinemia (WM)
Category
Telephone
Website
Address
নূরানী মসজিদ রোড, Dhaka Dhaka
Dhaka
1229
Alerts
Be the first to know and let us send you an email when Ibrutinib 140 mg - Ibrucent posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.